Drug-Plant Inspections Ebbed as Tainted Pills Flowed to U.S.

(Bloomberg) -- Inspections of foreign drug manufacturers by the U.S. Food and Drug Administration have fallen in recent years despite increasing worry about the safety and quality of generic medications, congressional investigators said. The GAO study, prepared for a hearing Tuesday on the U.S. drug supply chain by a House Energy and Commerce oversight subcommittee, paints a picture of the FDA dealing with a range of challenges as it oversees a vast global drug supply chain. [Extracted from the article]